Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2002
11/21/2002CA2447564A1 Nucleic acids and corresponding proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer
11/21/2002CA2447513A1 Compositions and methods for treating tumors bearing hmfg and cea antigens
11/21/2002CA2447503A1 Dwf12 and mutants thereof
11/21/2002CA2447485A1 Chemically assembled nano-scale circuit elements
11/21/2002CA2447445A1 Lentil plants having increased resistance to imidazolinone herbicides
11/21/2002CA2447444A1 Antisense permeation enhancers
11/21/2002CA2447431A1 Inhibitors of receptor activator of nf-kb and uses thereof
11/21/2002CA2447343A1 Method to induce neovascular formation and tissue regeneration
11/21/2002CA2447286A1 Random gene unidirectional antisense library
11/21/2002CA2447139A1 Specific binding proteins and uses thereof
11/21/2002CA2447116A1 Methods for treating liver disease and liver damage with growth hormone and foxm1b
11/21/2002CA2447114A1 Human antipneumococcal antibodies from non-human animals
11/21/2002CA2447110A1 Expression of membrane proteins using an adenylyl cyclase of mycobacterium tube rculosis
11/21/2002CA2447052A1 Combined approach to treatment of cancer using a c-myc antisense oligomer
11/21/2002CA2447050A1 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
11/21/2002CA2447017A1 Moraxella(branhamella) catarrhalis antigens
11/21/2002CA2447015A1 Insulin producing cells derived from human embryonic stem cells
11/21/2002CA2447004A1 Antisense modulation of ptp1b expression
11/21/2002CA2446991A1 Agents that regulate apoptosis
11/21/2002CA2446859A1 Transgenic animal model of bone mass modulation
11/21/2002CA2446821A1 Hbm variants that modulate bone mass and lipid levels
11/21/2002CA2446606A1 Inhibitors of dna methyltransferase isoforms
11/21/2002CA2446589A1 Methods for treating cancer
11/21/2002CA2446582A1 Reagents and methods for modulating dkk-mediated interactions
11/21/2002CA2446266A1 Isolated human receptor proteins, nucleic acid molecules encoding human receptor proteins, and uses thereof
11/21/2002CA2446180A1 Cytokine polypeptides
11/21/2002CA2446130A1 Methods and compositions for making emamectin
11/21/2002CA2446075A1 Novel maxizyme
11/21/2002CA2446050A1 Compositions and methods for array-based genomic nucleic acid analysis of biological molecules
11/21/2002CA2445366A1 Molecules for disease detection and treatment
11/21/2002CA2443964A1 Use of osteopontin for the treatment and/or prevention of neurologic diseases
11/21/2002CA2443627A1 Genes expressed in breast cancer as prognostic and therapeutic targets
11/21/2002CA2442635A1 Gastrokines and derived peptides including inhibitors
11/21/2002CA2442144A1 A helper dependent adenoviral vector system and methods for using the same
11/21/2002CA2429718A1 Human and non-human primate homologues of nkd protein, nucleic acid sequences encoding, and uses thereof
11/20/2002EP1258811A1 Exson-intron junction determining device, genetic region determining device, and determining method for them
11/20/2002EP1258532A1 Thermostable D-hydantoinase from Bacillus circulans and the application thereof
11/20/2002EP1258531A1 Compounds and methods for inhibiting axillary malodour
11/20/2002EP1258530A2 Gaba-A receptor subunits (alpha-2, alpha-3, alpha-5, alpha -6, beta-2) and transfected cells expressing them
11/20/2002EP1258529A2 FLIP Gene and FLIP Protein
11/20/2002EP1258528A1 Expression of membrane proteins using an adenylyl cyclase of Mycobacterium tuberculosis
11/20/2002EP1258494A1 Multiprotein complexes from eukaryotes
11/20/2002EP1258493A1 Cleavage and polyadenylation complex of precursor mRNA
11/20/2002EP1258287A2 Composite material sheet for analysis of substances originating from living body or analogues thereof
11/20/2002EP1257829A2 Complementation assay assessing protein solubility and folding
11/20/2002EP1257822A1 Her-2 binding antagonists
11/20/2002EP1257819A2 Method for identifying substances which modulate the activity of hyperpolarisation-activated cation channels
11/20/2002EP1257818A1 Enzyme-based gprotein-coupled receptor assay
11/20/2002EP1257695A1 Biomolecules having multiple attachment moieties for binding to a substrate surface
11/20/2002EP1257672A2 Method for detecting and quantifying adenovirus
11/20/2002EP1257671A1 Nucleic acid molecule encoding a mismatch endonuclease and methods of use thereof
11/20/2002EP1257670A2 Method for detecting cytosine methylation in dna samples
11/20/2002EP1257669A1 Antisense modulation of e2f transcription factor 3 expression
11/20/2002EP1257667A2 Electrochemical method for detecting nucleic acids
11/20/2002EP1257665A2 LIBRARIES OF OPTIMUM SUBSEQUENCE REGIONS OF mRNA AND GENOMIC DNA FOR CONTROL OF GENE EXPRESSION
11/20/2002EP1257663A2 Differential expression screening method
11/20/2002EP1257661A1 AN ASSAY FOR DETECTING VARIANT HAPATITIS B VIRUSES (HBVs) WHICH EXHIBIT ALTERED SENSITIVITY TO AGENTS
11/20/2002EP1257658A1 Method for increasing the gene expression of transfected genes
11/20/2002EP1257657A2 Autoregulatory expression vector for gene therapy
11/20/2002EP1257656A2 Recombinant aav packaging systems
11/20/2002EP1257655A2 Transgenic plants having resistance to a fungal disease
11/20/2002EP1257653A2 Phosphodiesterase type 7b
11/20/2002EP1257652A2 Human kinases and polynucleotides encoding the same
11/20/2002EP1257651A2 Nucleic acids of the human abc1 gene and applications thereof
11/20/2002EP1257650A1 Polymerase compositions and methods of use thereof
11/20/2002EP1257649A2 Corynebacterium glutamicum genes encoding metabolic pathway proteins
11/20/2002EP1257648A1 Antagonistic selective binding agents of osteoprotegerin binding protein
11/20/2002EP1257647A1 Control of membrane traffic
11/20/2002EP1257646A2 Transporters and ion channels
11/20/2002EP1257645A2 Fibroblast growth factor-23 molecules and uses thereof
11/20/2002EP1257644A2 103p2d6: tissue specific protein highly expressed in various cancers
11/20/2002EP1257643A2 Two pore potassium channels, nucleotide sequences encoding them, and methods of using same
11/20/2002EP1257642A1 Partners of ptb1 domain of fe65, preparation and uses
11/20/2002EP1257641A2 Method of modulating glycosylation pathways
11/20/2002EP1257640A2 Nucleic acids and polypeptides of drosophila melanogaster snf sodium-neurotransmitter symporter family cell surface receptors and methods of use
11/20/2002EP1257639A2 Nucleozymes with endonuclease activity
11/20/2002EP1257638A1 Bacterial isolates of the genus klebsiella, and an isomaltulose synthase gene isolated therefrom
11/20/2002EP1257637A2 Sphingosine kinases
11/20/2002EP1257636A2 Ozone and/or pathogen-inducible gene expression in plants
11/20/2002EP1257635A2 Lipid metabolism enzymes and polynucleotides encoding them
11/20/2002EP1257633A1 Presenilin deficient multipotent cell lines and screening methods for intramembrane regulated proteolytic activities using these lines
11/20/2002EP1257585A2 Antibodies that bind human interleukin-18 and methods of making and using
11/20/2002EP1257584A2 Humanized antibodies that sequester amyloid beta peptide
11/20/2002EP1257581A1 Compounds related to or derived from gfr alpha 4 and their use
11/20/2002EP1257579A2 Novel human g protein coupled receptor proteins and polynucleotides encoding the same
11/20/2002EP1257578A2 Transporters and ion channels
11/20/2002EP1257573A2 New transcription factor carp-2
11/20/2002EP1257572A2 Narc-1, subtilase-like homologs
11/20/2002EP1257569A2 Cold-adapted equine influenza viruses
11/20/2002EP1257565A1 Mucin-1 derived antigens and their use in immunotherapy
11/20/2002EP1257564A1 Process of purification of hcg and recombinant hcg purified by that method
11/20/2002EP1257561A1 Staphylococcal gtpase obgcleotide sequence encoding staphylococcal gtp-binding protein
11/20/2002EP1257560A1 Bcl-2-like polynucleotides, polypeptides, and antibodies
11/20/2002EP1257559A1 Mammalian sphingosine-1-phosphate phosphatase
11/20/2002EP1257364A2 Container for nucleic acid analysis
11/20/2002EP1257355A2 Microarray fabrication techniques and apparatus
11/20/2002EP1257354A2 Microarray fabrication techniques and apparatus
11/20/2002EP1257295A2 Factor vii or viia-like molecules
11/20/2002EP1257292A1 Use of il-18 inhibitors
11/20/2002EP1257291A1 Novel antibody with specificity for colon cancer